Aurora Cannabis Q3 revenue up 12% YoY to $76.2mln, EBITDA at $18.5mln.

miércoles, 4 de febrero de 2026, 7:08 am ET1 min de lectura
ACB--

• Aurora Cannabis Q3 revenue up 7% YoY to $94.2mln • Medical cannabis revenue up 12% YoY to $76.2mln • Adjusted EBITDA at $18.5mln • Adjusted net income at $7.2mln • Free cash flow at $15.5mln • Cash and short-term investments at $154.4mln • Debt-free cannabis business • Strong growth in international markets, led by Germany and Poland

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios